Commercial & Medical Affairs - software & AI news

Daily news on software, AI, and companies shaping commercial & medical affairs.

Showing 82 results
A minimalist dollar sign representing pharmaceutical marketing finances.

May 14, 2026

Why 75 Top Pharma Execs Are Ditching Fragmented Marketing Stacks

A coalition of 75 pharmaceutical executives has rallied behind a new marketing operations platform, emphasizing the urgent need for streamlined commercial technology in the life sciences sector. This initiative, revealed at the Doceree Health Decode: The Makers Summit 2026 in New York, seeks to address the inefficiencies caused by fragmented marketing systems.The executives, representing companies like Sanofi and Bristol Myers Squibb, collectively manage over $40 billion in annual brand spending
A test tube with a colorful liquid sample on a lab bench

May 14, 2026

BranchLab Lands $26 Million in Series A

BranchLab, an AI platform focused on pharmaceutical commercialization, has successfully secured $26 million in Series A funding, increasing its total funding to $35 million.This funding round was led by McKesson Ventures, which is known for investing in healthcare technology aimed at enhancing the efficiency and quality of healthcare delivery. Other notable investors included FCA Venture Partners, Sanofi Ventures, and AIX Ventures, indicating a strong interest in innovative solutions within the
A test tube in a laboratory setting

May 14, 2026

BranchLab: $26 Million Series A Raised To Expand AI Platform For Pharma Commercialization

BranchLab has successfully secured $26 million in Series A funding, spearheaded by McKesson Ventures, with additional contributions from FCA Venture Partners, Sanofi Ventures, and AIX Ventures. This funding boosts the company's total to $35 million, aimed at enhancing its AI platform for pharmaceutical commercialization.The platform seeks to revolutionize pharmaceutical commercialization processes by streamlining patient identification, audience segmentation, and performance measurement in real
A syringe and vial in a clinical lab setting

May 14, 2026

SwishX Launches Agentic AI Platform for Pharma and MedTech Industry

SwishX has launched an innovative Agentic AI platform aimed at transforming the pharmaceutical and medtech industries. This Bengaluru-based startup seeks to enhance sales, marketing, and distribution by leveraging advanced artificial intelligence technologies. With a target of securing over 100 enterprise clients and achieving $5 million in annual recurring revenue by FY 2026–27, SwishX is also planning to expand its reach into emerging markets such as Latin America, Southeast Asia, and Africa.T
A minimalist illustration of a pill bottle and gear symbolizing pharmaceutical automation.

May 14, 2026

AI will eliminate 70-80% of current pharma commercial processes: Dushyant Sapre, Founder and CEO, SwishX

Dushyant Sapre, the Founder and CEO of SwishX, asserts that AI is poised to revolutionize the pharmaceutical industry by automating a significant portion of commercial processes, potentially eliminating 70-80% of them in the next decade. This perspective arises from the unique challenges faced by India's pharma sector, particularly in the realm of generic drug distribution, where operational efficiency is paramount.SwishX positions itself as an AI-native operating system tailored for pharma sale
A syringe and ampoule on a laboratory shelf in soft lighting

May 14, 2026

SwishX Launches Agentic AI Platform for Pharma & Medtech, Raises $2.2 Mn Seed Funding

SwishX has introduced its Agentic AI platform tailored for the pharmaceutical and medtech sectors, alongside securing $2.2 million in seed funding from various investors.The Bengaluru-based startup, founded by former executives from Google and Amazon, aims to achieve $5 million in annual recurring revenue and onboard over 100 enterprise clients by FY 2026–27. The company is set to expand its reach into emerging markets, including regions in Latin America, Southeast Asia, the Middle East, Africa,
A syringe filled with a pharmaceutical compound in a dimly lit lab setting.

May 13, 2026

SwishX Launches Agentic AI Platform For Pharma

SwishX has launched an innovative Agentic AI platform tailored for the pharmaceutical and medtech sectors, aiming to revolutionize sales and marketing processes through advanced artificial intelligence.Based in Bengaluru, SwishX is targeting a contracted annual recurring revenue of $5 million and plans to acquire over 100 enterprise clients by the end of the fiscal year 2026-27. The startup has recently secured $2.2 million in seed funding to support its expansion into various emerging markets,
A medical chart and stethoscope in a clinical setting

May 12, 2026

HCPs Are Already Using AI. Is Your Commercial Model up to speed?

As artificial intelligence transitions from pilot projects to standard practice in healthcare, pharmaceutical engagement strategies must evolve accordingly.AI is increasingly integrated into clinical workflows, enabling healthcare professionals (HCPs) to access and interpret vast amounts of medical information efficiently. Reports indicate that 64% of European countries are utilizing AI-assisted diagnostics, with around 30% of UK general practitioners incorporating AI tools during consultations.
A flat illustration of a pill on a solid background.

May 12, 2026

Founded by Ex-Google and Amazon Execs, SwishX Launches World’s First Agentic AI Platform for Pharma and Medtech

SwishX has launched an innovative Agentic AI platform designed specifically for the pharmaceutical and medtech sectors, aiming to revolutionize sales, marketing, and distribution.Based in Bengaluru, the startup has set ambitious goals, targeting $5 million in annual recurring revenue and over 100 enterprise clients by the end of the fiscal year 2026-27. With $2.2 million in seed funding, SwishX plans to expand into various emerging markets, which present a substantial $400 billion opportunity in
Flat design illustration of a data flow in pharmaceutical operations

May 12, 2026

SwishX raises $2.2 million seed to launch agentic AI for pharma and MedTech

SwishX has launched a groundbreaking AI platform tailored for the pharmaceutical and MedTech sectors, raising $2.2 million in seed funding to support its mission of transforming commercial operations.The Bengaluru-based startup's new Agentic AI platform aims to address operational inefficiencies prevalent in the pharmaceutical and medical device industries. Traditional methods often rely on outdated practices, such as spreadsheets and manual workflows, which can hinder timely decision-making and
A vial and syringe on a lab shelf in low light

May 12, 2026

SwishX Launches World’s First Agentic AI Platform for Pharma, Medtech

SwishX has launched a groundbreaking Agentic AI platform tailored for the pharmaceutical and medtech industries, aiming to enhance business operations through advanced artificial intelligence.The Bengaluru-based startup is targeting a significant growth trajectory, aiming for $5 million in contracted annual recurring revenue and over 100 enterprise clients by the end of fiscal year 2026-27. With a recent seed funding of $2.2 million from various investors, SwishX plans to expand into key emergin
A minimalist representation of a contract with a checkmark, symbolizing agreements in pharma and medtech.

May 12, 2026

SwishX launches Agentic AI platform for pharma and medtech firms, raises $2.2 million seed funding

SwishX has introduced a groundbreaking Agentic AI platform tailored specifically for the pharmaceutical and medtech sectors, backed by $2.2 million in seed funding.The Bengaluru-based startup aims to revolutionize commercial operations, focusing on sales, marketing, tenders, contracts, and distribution. With the recent funding from investors like Powerhouse Ventures and Blume Ventures, SwishX is targeting over 100 enterprise clients and anticipates achieving $5 million in annual recurring revenu